GCM
PODD icon

Genus Capital Management’s Insulet PODD Stock Holding History

Genus Capital Management’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,603
Closed -$4.33M – 320
2024
Q4 		$4.33M Buy
+16,603
New +$4.18M 0.59% 59

Other funds holding PODD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Genus Capital Management's PODD Position: Q1 2026 in Review

Genus Capital Management sold out of Insulet (PODD) in Q1 2026, closing a stake of 1,271 shares — an estimated $361K sold.

Genus Capital Management first reported a position in PODD in Q1 2025 and held it in 4 quarters. The position peaked at $5.03M in Q2 2025. 785 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Genus Capital Management reported no remaining Insulet position as of Q1 2026 after selling out during the quarter.
  • Genus Capital Management sold 1,271 Insulet shares in Q1 2026, an estimated $361K.
  • Genus Capital Management first reported a position in Insulet in Q1 2025 and held it in 4 quarters.
  • Genus Capital Management's Insulet position peaked at $5.03M in Q2 2025.
  • 785 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Genus Capital Management's 13F filing for Q1 2026, filed 4 May 2026.